As of June 2023 Roche has a market cap of $260.15 Billion. This makes Roche the world's 33th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $260.15 B | 0.23% |
2022 | $259.55 B | -27.83% |
2021 | $359.63 B | 20.2% |
2020 | $299.20 B | 8.27% |
2019 | $276.35 B | 31.2% |
2018 | $210.64 B | -1.97% |
2017 | $214.86 B | 9.77% |
2016 | $195.74 B | -17.9% |
2015 | $238.41 B | 2.92% |
2014 | $231.65 B | -2.73% |
2013 | $238.15 B | -24.51% |
2012 | $315.46 B | 114.14% |
2011 | $147.31 B | 15.59% |
2010 | $127.44 B | -14.38% |
2009 | $148.85 B | 9.99% |
2008 | $135.33 B | -10.67% |
2007 | $151.50 B | -1.96% |
2006 | $154.53 B |
On Jun 9th, 2023 the market cap of Roche was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $415.82 B | 59.84% | ๐บ๐ธ USA |
![]() Novartis NVS | $213.93 B | -17.77% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $219.99 B | -15.43% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $176.83 B | -32.03% | ๐บ๐ธ USA |
![]() Amgen AMGN | $116.88 B | -55.07% | ๐บ๐ธ USA |
![]() Sanofi SNY | $127.98 B | -50.80% | ๐ซ๐ท France |
![]() Becton Dickinson BDX | $71.42 B | -72.54% | ๐บ๐ธ USA |
![]() Merck MRK | $280.91 B | 7.98% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $71.17 B | -72.64% | ๐ฌ๐ง UK |